In terms of the contribution to acquired chemoresistance, the present IHC and qRT–PCR data showed higher MRP2 expression in resected tumours with NACT compared with those without NACT, implying residual tumours after NACT acquired the feature of chemoresistance. The gene discussed is ABCC2; the disease is neoplasm.